Detalles de la búsqueda
1.
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.
Hepatology
; 2023 Nov 06.
Artículo
Inglés
| MEDLINE | ID: mdl-37934624
2.
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Ann Hepatol
; 28(6): 101141, 2023 Jul 17.
Artículo
Inglés
| MEDLINE | ID: mdl-37468096
3.
Liver resection for single large hepatocellular carcinoma: a prognostic factors study.
Ann Hepatol
; 27(6): 100739, 2022.
Artículo
Inglés
| MEDLINE | ID: mdl-35781089
4.
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta.
J Hepatol
; 73(5): 1046-1062, 2020 11.
Artículo
Inglés
| MEDLINE | ID: mdl-32634548
5.
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Gastroenterology
; 156(4): 997-1009.e5, 2019 03.
Artículo
Inglés
| MEDLINE | ID: mdl-30768988
6.
Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
Hepatology
; 70(3): 939-954, 2019 09.
Artículo
Inglés
| MEDLINE | ID: mdl-30569448
7.
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
Gastroenterology
; 155(5): 1436-1450.e6, 2018 11.
Artículo
Inglés
| MEDLINE | ID: mdl-30031138
8.
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Gastroenterology
; 155(2): 431-442.e10, 2018 08.
Artículo
Inglés
| MEDLINE | ID: mdl-29729258
9.
Cascade of care for migrants tested Hepatitis C antibodies positive in France through a systematic screening programme: The PRECAVIR study.
J Viral Hepat
; 26(12): 1496-1499, 2019 12.
Artículo
Inglés
| MEDLINE | ID: mdl-31433886
10.
Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues.
J Viral Hepat
; 26(2): 278-286, 2019 02.
Artículo
Inglés
| MEDLINE | ID: mdl-30339311
11.
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
J Viral Hepat
; 26(3): 384-396, 2019 03.
Artículo
Inglés
| MEDLINE | ID: mdl-30380181
12.
Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort).
Hepatology
; 68(4): 1534-1548, 2018 10.
Artículo
Inglés
| MEDLINE | ID: mdl-29637581
13.
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.
Hepatology
; 68(4): 1245-1259, 2018 10.
Artículo
Inglés
| MEDLINE | ID: mdl-29663511
14.
Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort.
Liver Int
; 39(1): 136-146, 2019 01.
Artículo
Inglés
| MEDLINE | ID: mdl-29947467
15.
Assessing the cost-effectiveness of hepatitis C screening strategies in France.
J Hepatol
; 69(4): 785-792, 2018 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-30227916
16.
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
Gastroenterology
; 152(1): 142-156.e2, 2017 01.
Artículo
Inglés
| MEDLINE | ID: mdl-27641509
17.
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients.
Am Heart J
; 198: 4-17, 2018 04.
Artículo
Inglés
| MEDLINE | ID: mdl-29653647
18.
Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).
Gut
; 66(2): 330-341, 2017 02.
Artículo
Inglés
| MEDLINE | ID: mdl-26511797
19.
Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.
Clin Infect Dis
; 64(11): 1615-1618, 2017 Jun 01.
Artículo
Inglés
| MEDLINE | ID: mdl-28369411
20.
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
J Hepatol
; 66(3): 552-559, 2017 03.
Artículo
Inglés
| MEDLINE | ID: mdl-27899297